Contact Details
Dr Gregory Roger
Chief Executive Officer
Unit 2, 12 Frederick Street
St Leonards NSW 2065
W www.asdm.com.au...
E advsurg@asdm.com.au...
Advanced Surgical Design & Manufacture
The Peripheral Access Device
Each day in Australia ten people are forced to undergo a leg amputation, resulting in significant pain, discomfort and reduction in mobility, and at a cost of up to $100,000 including the procedure and ongoing care.
The Peripheral Access Device (PAD) from Advanced Surgical Design & Manufacture (ASDM) can prevent many of these amputations by enabling a safe and reliable method of intra-arterial intervention.
The PAD is inserted partially through the skin into the artery, and once inserted it can be used to deliver high pressures and flows into the artery. The cells lining the artery that form the blood contacting wall get ruffled by the higher flow, with the resulting stress stimulating cellular regrowth and building of collateral vessels
The attachment point has been designed to handle high pressures and flows used in the treatment, and the design ensures that the PAD is watertight. The device can be left in situ for the duration of the treatment and shut off when not in use, preventing clotting. It can then be reopened at will, enabling safe access to the artery on a period basic.
The PAD may also have application for other treatments, including isolated organ profusion. In this treatment organs are isolated from the circulatory system and filled with chemotherapy agents for treatment of a range of difficult cancers, such as pancreatic cancer.
The potential for the PAD is strong, given that 1000 legs are amputated each day in the Western world. The PAD has been tested in human trials in hospitals in Australia, saving the legs of 7 of the initial 15 amputation candidates with which it had been trialed. Further trials are scheduled, and ASDM has also received interest for trials in Europe.